BURLINGTON, Mass. - Azenta, Inc. (NASDAQ: AZTA), a global provider of life sciences solutions, announced the election of ...

Azenta, Inc. (NASDAQ:AZTA), a company specializing in special industry machinery with a market capitalization of $2.46 billion, announced today that it has classified its B Medical (TASE:PMCN) Systems ...

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2025 earnings which ended on December 31, 2024, on Wednesday ...

Azenta, Inc. shares have surged over 30% since Nov 2024 due to S&P 600 inclusion and an analyst upgrade, despite somewhat ...

Over the last three months, we've seen significantly more insider buying, than insider selling, at Azenta. In total, four insiders bought US$1.3m worth of shares in that time. On the other hand, ...

Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter financial results.

The UK Biocentre in Milton Keynes is set to enhance its large-scale biomedical research capabilities with the addition of a new high-density automated storage system. The BioArc Ultra, developed ...

Azenta (AZTA) announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample storage in ...

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences. Experts from the Women’s Brain Foundation and bit.bio will explore the importance of ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Azenta, Inc has introduced a long-read Whole Genome Sequencing (WGS) test for clinical applications, becoming the first ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...